PX1 Research provides certified, high-purity Chonluten (Glu-Asp-Gly) for academic, industrial, and clinical laboratory investigations into mucosal epithelial dynamics. Every batch undergoes comprehensive mass spectrometry, high-performance liquid chromatography, and endotoxin analysis to guarantee rigorous analytical standards for in vitro and animal models.
PX1 Research provides certified, high-purity Chonluten (Glu-Asp-Gly) for academic, industrial, and clinical laboratory investigations into mucosal epithelial dynamics. Every batch undergoes comprehensive mass spectrometry, high-performance liquid chromatography, and endotoxin analysis to guarantee rigorous analytical standards for in vitro and animal models.
When identifying a qualified mucosal tissue function Chonluten supplier, laboratory researchers require validated peptide purity, lot-specific analytical verification, and reliable batch-to-batch consistency. PX1 Research supplies research-grade Chonluten (Glu-Asp-Gly) synthesized in USA-based, GMP-compliant facilities. Every lot is verified via reverse-phase HPLC and mass spectrometry to ensure sequence fidelity, high purity, and minimal endotoxin burden for in vitro cellular models and preclinical animal studies.
Chonluten is a synthetic tripeptide composed of L-glutamic acid, L-aspartic acid, and glycine (EDG). Identified within the class of short peptide bioregulators, Chonluten has attracted significant focus in cell biology and pulmonary research. Investigators seeking to purchase this compound for experimental use must ensure their supplier provides full analytical transparency, including accessible Certificate of Analysis (COA) documentation for every manufactured batch.
Chonluten is characterized by its low molecular weight and distinct tripeptide sequence: L-alpha-glutamyl-L-alpha-aspartyl-glycine ($C_{11}H_{17}N_{3}O_{8}$, MW ~303.27 g/mol). Its simple structural backbone allows for high solubility in aqueous buffer systems, making it an ideal candidate for standardized research peptide protocols. Short peptide bioregulators like Chonluten are theorized to penetrate cell membranes efficiently and interact directly with nucleosomal DNA or nuclear proteins.
In cell-free and cell-culture assays, short acidic peptides containing aspartic and glutamic acid residues demonstrate site-specific interactions with histones and double-stranded DNA. This structural property underpins much of the ongoing scientific inquiry into how short peptides regulate transcriptional activity without altering primary genomic sequences. Researchers evaluating epithelial barrier peptides utilize Chonluten to study basic gene expression pathways involved in structural protein synthesis.
Preclinical studies in rodent models and primary tissue explants suggest that Chonluten plays a key regulatory role in maintaining bronchial and mucosal epithelial integrity. In murine models exposed to environmental stressors or toxic aerosol agents, administration of Chonluten was observed to support normal histological architecture within bronchial mucosal layers, reducing inflammatory cell infiltration and preserving ciliated epithelial morphology.
In vitro data indicate that exposure to Chonluten in bronchial epithelial cell cultures correlates with altered expression profiles of pro-inflammatory cytokines, including TNF-alpha and IL-6, following lipopolysaccharide (LPS) challenge. Furthermore, animal studies demonstrate enhanced expression of endogenous surfactant proteins (such as SFTPA1 and SFTPB) in alveolar type II cells following peptide administration. These findings highlight Chonluten's utility as a primary research compound for investigating respiratory repair mechanisms and mucosal homeostatic control.
The mechanistic framework surrounding Chonluten centers on its potential for epigenetic regulation and chromatin interaction. Experimental models indicate that short peptides migrate into the cell nucleus, binding to specific promoter regions of DNA. This interaction is hypothesized to de-condense heterochromatin, thereby facilitating RNA polymerase accessibility to genes responsible for structural homeostasis and anti-apoptotic signaling pathways.
Beyond direct nuclear interactions, in vitro assays demonstrate that Chonluten exposure modulates intracellular oxidative stress markers. In hydrogen peroxide-stressed cellular models, treatement with short tripeptides reduced accumulated reactive oxygen species (ROS) while preserving mitochondrial membrane potential. By stabilizing cellular redox states and supporting tight-junction gene transcription (such as Claudin and Occludin family members), Chonluten serves as a robust tool for investigating epithelial barrier function under hypoxic or oxidative challenges.
To properly contextualize Chonluten within short-chain bioregulatory peptide research, investigators frequently compare its activity against structurally analogous compounds. While Chonluten (Glu-Asp-Gly) specifically targets mucosal and bronchial epithelial cell lines, Bronchogen (Ala-Glu-Asp-Leu) represents a tetrapeptide sequence also evaluated for airway remodeling and pulmonary gene expression. Both compounds demonstrate selective activity in respiratory models, but vary in their specific binding affinities and transcriptional target profiles.
Similarly, researchers studying broader immunological and mucosal homeostasis often compare Chonluten to Thymogen (Glu-Trp), a dipeptide focused on T-cell maturation pathways, and general mucosal repair agents such as BPC-157. Comparative studies show that while systemic repair peptides influence angiogenic and focal adhesion cascades across multiple tissue types, short bioregulatory tripeptides like Chonluten exhibit more targeted effects on epithelial cell transcription and localized surfactant production. A complete overview of these target profiles is detailed in our bioregulatory peptides overview.
Proper handling and reconstitution protocols are vital to maintain the structural stability and bioactivity of Chonluten in a laboratory setting. Chonluten is supplied as a lyophilized (freeze-dried) powder to maximize shelf-life. Prior to reconstituted use, peptide vials should be allowed to equilibrate to room temperature inside a desiccated environment to avoid condensation formation on the inner vial surfaces.
For standard cell culture and in vitro assays, lyophilized Chonluten should be reconstituted using sterile, bacteriostatic water or sterile phosphate-buffered saline (PBS, pH 7.4). Avoid vigorous vortexing, as mechanical shear stress can disrupt peptide integrity; instead, gently swirl the solution until complete dissolution occurs. Stock solutions should be aliquoted into single-use polypropylene tubes and stored at -20°C or -80°C to prevent degradation from repeated freeze-thaw cycles. Detailed reconstitution guidelines and concentration calculations are accessible via the PX1 Research Library.
The validity of any preclinical assay relies entirely on the purity and chemical identity of the research compounds used. Impurities, incomplete synthesis side-products, or trace bacterial endotoxins can induce confounding cellular toxicity or unspecific immune responses in vitro. Therefore, sourcing from a vetted mucosal tissue function Chonluten supplier requires verification of rigorous analytical testing.
At PX1 Research, every batch of Chonluten undergoes dual-stage chemical verification: Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to verify chromatographic purity exceeds 98.0%, and Electrospray Ionization Mass Spectrometry (ESI-MS) to verify precise molecular weight and sequence identity. Additionally, because mucosal and pulmonary cell lines are acutely sensitive to bacterial lipopolysaccharides, all lots undergo Chromogenic Reagent LAL Endotoxin Testing to confirm endotoxin levels remain below strictly controlled thresholds (<0.01 EU/mg).
Selecting a research peptide vendor requires careful scrutiny of manufacturing practices, laboratory certifications, and transparency. Researchers should avoid suppliers that fail to publish lot-specific analytical data or those operating without ISO-accredited testing facilities. A reliable supplier should maintain comprehensive traceability from raw amino acid coupling through final lyophilization.
PX1 Research establishes the standard for peptide supply by maintaining ISO 17025 accredited analytical testing standards and operating within US-based, GMP-compliant facilities. Every product shipment includes direct access to batch-specific COAs, ensuring total compliance with institutional safety and verification requirements. Laboratories seeking bulk quantities or specialized experimental packaging can set up streamlined procurement through our dedicated wholesale program.
Experimental workflows require consistent, prompt supply chain execution to prevent research delays. PX1 Research operates dual fulfillment centers located in California and Arizona, facilitating same-day shipping for all orders placed before 3:00 PM EST Monday through Friday. Cold-chain packaging options and ambient temperature stability data ensure that peptide integrity is preserved throughout transport.
Whether procuring standard laboratory quantities or organizing large-scale comparative screens across our entire catalog of research peptides, PX1 Research offers flexible ordering options, dedicated account management, and reliable delivery protocols designed specifically for research institutions, universities, and private biotechnology laboratories.
What is Chonluten and what is its primary focus in research?
Chonluten is a synthetic tripeptide composed of L-glutamic acid, L-aspartic acid, and glycine (Glu-Asp-Gly). In laboratory research, it is studied for its role as a bioregulatory peptide that modulates gene expression, surfactant production, and epithelial barrier function in mucosal and respiratory tissue models.
How does PX1 Research verify the purity of its Chonluten?
Every lot of Chonluten offered by PX1 Research undergoes rigorous testing, including Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm >98% chemical purity, Mass Spectrometry (MS) to verify molecular weight, and LAL assays to ensure low endotoxin levels.
What solvent should be used to reconstitute Chonluten for laboratory assays?
Chonluten is highly soluble in aqueous solutions. It is typically reconstituted using sterile bacteriostatic water, sterile normal saline, or phosphate-buffered saline (PBS, pH 7.4) depending on the specific requirements of the in vitro or cell culture protocol.
What are the recommended storage conditions for Chonluten powder and liquid solution?
Lyophilized Chonluten powder should be stored at -20°C for short-term research or -80°C for long-term storage, protected from light and moisture. Reconstituted liquid stock solutions should be aliquoted and stored at -20°C or -80°C; repeated freeze-thaw cycles must be avoided.
How does Chonluten compare to Bronchogen in experimental models?
Both Chonluten (tripeptide Glu-Asp-Gly) and Bronchogen (tetrapeptide Ala-Glu-Asp-Leu) are short bioregulatory peptides evaluated in respiratory and mucosal tissue models. While both influence gene expression in bronchial cells, Chonluten specifically targets surfactant production and chromatin structure in alveolar and mucosal lines, whereas Bronchogen is frequently studied for broader airway tissue remodeling.
Why is endotoxin testing critical when purchasing Chonluten for cell culture?
Bacterial endotoxins (lipopolysaccharides) can trigger severe inflammatory signaling pathways in epithelial and mucosal cell cultures, creating confounding variable data. Low endotoxin limits (<0.01 EU/mg) ensure that observed cellular responses are driven by the peptide itself rather than bacterial contamination.
Does PX1 Research provide bulk supply options for institutional laboratories?
Yes, PX1 Research offers institutional pricing, custom vial configurations, and bulk procurement options for research organizations. Inquiries can be submitted directly through our wholesale program portal.
Where are PX1 Research peptides manufactured and shipped from?
All PX1 Research compounds are manufactured in US-based, GMP-compliant facilities and shipped directly from dual fulfillment facilities located in California and Arizona to ensure fast domestic dispatch.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.